Global Bipolar Disorder Therapeutic Market Research Report 2023(Status and Outlook)

Global Bipolar Disorder Therapeutic Market Research Report 2023(Status and Outlook)



Report Overview

Bipolar disorder, also known as manic-depressive disorder, is a mental illness. It is a mental health problem that primarily affects mood. Symptoms of bipolar disorder are extreme irritability or agitation, a period of feeling empty, loss of interest in normal activities, sleep problems, etc. According to Pfizer, Inc., bipolar disorder affects over 5 million people in the U.S. Bipolar episodes are characterized by a drastic change in behavior and mood, and range from joyful and overexcited (manic episodes) to extremely sad and hopeless (depressive state). These disorders have different types of episodes such as manic episodes, hypomanic episodes, depressive episodes, and mixed episodes. Causes of bipolar disorders include childhood trauma, stressful life events, self-esteem problems, and genetic inheritance. People across the world marked “March 30” as a World Bipolar Day to spread awareness about the disorder and erase the stigma of mental illness. Large number of people suffering from this mental condition resort to drinking to lift their mood. According to the National Institute on Alcohol Abuse and Alcoholism, 27.6% of the people with bipolar disorder become addicted to alcohol, while over 16% engaged in alcohol abuse.

The growing need to reduce the financial burden of bipolar disorder will drive the growth prospects for the global bipolar disorder therapeutic market until the end of 2021. It has been observed that governments and companies across the globe are increasingly organizing awareness camps to raise disease awareness among the public, reduce the burden of mental disorders in vulnerable groups, ensure the rights of people with mental disorders, and make treatment facilities accessible to them. Consequently, such awareness initiatives help to curb the overall monetary loss, reduce their effect on the global economy, and improve the quality of life for patients. Such factors will raise public awareness about mental disorders and treatments and in turn, propel the rate of revenue generation in the market.

The Global Bipolar Disorder Therapeutic Market Size was estimated at USD 3855.30 million in 2022 and is projected to reach USD 4428.53 million by 2029, exhibiting a CAGR of 2.00% during the forecast period.

Bosson Research’s latest report provides a deep insight into the global Bipolar Disorder Therapeutic market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.

The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Bipolar Disorder Therapeutic Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.

In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Bipolar Disorder Therapeutic market in any manner.

Global Bipolar Disorder Therapeutic Market: Market Segmentation Analysis

The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.

Key Company

Eli Lilly

Bristol-Myers Squibb

AstraZeneca

Allergan

Astellas Pharma

GlaxoSmithKline

Janssen Pharmaceuticals

Market Segmentation (by Type)

Antipsychotics

Anticonvulsants

Mood Stabilizers

Market Segmentation (by Application)

OB-GYN

Urology

Vascular & Nervous System

Renal / Digestive

Musculoskeletal

Other

Geographic Segmentation

North America (USA, Canada, Mexico)

Europe (Germany, UK, France, Russia, Italy, Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)

South America (Brazil, Argentina, Columbia, Rest of South America)

The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)

Key Benefits of This Market Research:

Industry drivers, restraints, and opportunities covered in the study

Neutral perspective on the market performance

Recent industry trends and developments

Competitive landscape & strategies of key players

Potential & niche segments and regions exhibiting promising growth covered

Historical, current, and projected market size, in terms of value

In-depth analysis of the Bipolar Disorder Therapeutic Market

Overview of the regional outlook of the Bipolar Disorder Therapeutic Market:

Key Reasons to Buy this Report:

Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change

This enables you to anticipate market changes to remain ahead of your competitors


1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Bipolar Disorder Therapeutic
1.2 Key Market Segments
1.2.1 Bipolar Disorder Therapeutic Segment by Type
1.2.2 Bipolar Disorder Therapeutic Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Bipolar Disorder Therapeutic Market Overview
2.1 Global Market Overview
2.1.1 Global Bipolar Disorder Therapeutic Market Size (M USD) Estimates and Forecasts (2018-2029)
2.1.2 Global Bipolar Disorder Therapeutic Sales Estimates and Forecasts (2018-2029)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Bipolar Disorder Therapeutic Market Competitive Landscape
3.1 Global Bipolar Disorder Therapeutic Sales by Manufacturers (2018-2023)
3.2 Global Bipolar Disorder Therapeutic Revenue Market Share by Manufacturers (2018-2023)
3.3 Bipolar Disorder Therapeutic Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Bipolar Disorder Therapeutic Average Price by Manufacturers (2018-2023)
3.5 Manufacturers Bipolar Disorder Therapeutic Sales Sites, Area Served, Product Type
3.6 Bipolar Disorder Therapeutic Market Competitive Situation and Trends
3.6.1 Bipolar Disorder Therapeutic Market Concentration Rate
3.6.2 Global 5 and 10 Largest Bipolar Disorder Therapeutic Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Bipolar Disorder Therapeutic Industry Chain Analysis
4.1 Bipolar Disorder Therapeutic Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Bipolar Disorder Therapeutic Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Bipolar Disorder Therapeutic Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Bipolar Disorder Therapeutic Sales Market Share by Type (2018-2023)
6.3 Global Bipolar Disorder Therapeutic Market Size Market Share by Type (2018-2023)
6.4 Global Bipolar Disorder Therapeutic Price by Type (2018-2023)
7 Bipolar Disorder Therapeutic Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Bipolar Disorder Therapeutic Market Sales by Application (2018-2023)
7.3 Global Bipolar Disorder Therapeutic Market Size (M USD) by Application (2018-2023)
7.4 Global Bipolar Disorder Therapeutic Sales Growth Rate by Application (2018-2023)
8 Bipolar Disorder Therapeutic Market Segmentation by Region
8.1 Global Bipolar Disorder Therapeutic Sales by Region
8.1.1 Global Bipolar Disorder Therapeutic Sales by Region
8.1.2 Global Bipolar Disorder Therapeutic Sales Market Share by Region
8.2 North America
8.2.1 North America Bipolar Disorder Therapeutic Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Bipolar Disorder Therapeutic Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Bipolar Disorder Therapeutic Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Bipolar Disorder Therapeutic Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Bipolar Disorder Therapeutic Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profile
9.1 Eli Lilly
9.1.1 Eli Lilly Bipolar Disorder Therapeutic Basic Information
9.1.2 Eli Lilly Bipolar Disorder Therapeutic Product Overview
9.1.3 Eli Lilly Bipolar Disorder Therapeutic Product Market Performance
9.1.4 Eli Lilly Business Overview
9.1.5 Eli Lilly Bipolar Disorder Therapeutic SWOT Analysis
9.1.6 Eli Lilly Recent Developments
9.2 Bristol-Myers Squibb
9.2.1 Bristol-Myers Squibb Bipolar Disorder Therapeutic Basic Information
9.2.2 Bristol-Myers Squibb Bipolar Disorder Therapeutic Product Overview
9.2.3 Bristol-Myers Squibb Bipolar Disorder Therapeutic Product Market Performance
9.2.4 Bristol-Myers Squibb Business Overview
9.2.5 Bristol-Myers Squibb Bipolar Disorder Therapeutic SWOT Analysis
9.2.6 Bristol-Myers Squibb Recent Developments
9.3 AstraZeneca
9.3.1 AstraZeneca Bipolar Disorder Therapeutic Basic Information
9.3.2 AstraZeneca Bipolar Disorder Therapeutic Product Overview
9.3.3 AstraZeneca Bipolar Disorder Therapeutic Product Market Performance
9.3.4 AstraZeneca Business Overview
9.3.5 AstraZeneca Bipolar Disorder Therapeutic SWOT Analysis
9.3.6 AstraZeneca Recent Developments
9.4 Allergan
9.4.1 Allergan Bipolar Disorder Therapeutic Basic Information
9.4.2 Allergan Bipolar Disorder Therapeutic Product Overview
9.4.3 Allergan Bipolar Disorder Therapeutic Product Market Performance
9.4.4 Allergan Business Overview
9.4.5 Allergan Bipolar Disorder Therapeutic SWOT Analysis
9.4.6 Allergan Recent Developments
9.5 Astellas Pharma
9.5.1 Astellas Pharma Bipolar Disorder Therapeutic Basic Information
9.5.2 Astellas Pharma Bipolar Disorder Therapeutic Product Overview
9.5.3 Astellas Pharma Bipolar Disorder Therapeutic Product Market Performance
9.5.4 Astellas Pharma Business Overview
9.5.5 Astellas Pharma Bipolar Disorder Therapeutic SWOT Analysis
9.5.6 Astellas Pharma Recent Developments
9.6 GlaxoSmithKline
9.6.1 GlaxoSmithKline Bipolar Disorder Therapeutic Basic Information
9.6.2 GlaxoSmithKline Bipolar Disorder Therapeutic Product Overview
9.6.3 GlaxoSmithKline Bipolar Disorder Therapeutic Product Market Performance
9.6.4 GlaxoSmithKline Business Overview
9.6.5 GlaxoSmithKline Recent Developments
9.7 Janssen Pharmaceuticals
9.7.1 Janssen Pharmaceuticals Bipolar Disorder Therapeutic Basic Information
9.7.2 Janssen Pharmaceuticals Bipolar Disorder Therapeutic Product Overview
9.7.3 Janssen Pharmaceuticals Bipolar Disorder Therapeutic Product Market Performance
9.7.4 Janssen Pharmaceuticals Business Overview
9.7.5 Janssen Pharmaceuticals Recent Developments
10 Bipolar Disorder Therapeutic Market Forecast by Region
10.1 Global Bipolar Disorder Therapeutic Market Size Forecast
10.2 Global Bipolar Disorder Therapeutic Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Bipolar Disorder Therapeutic Market Size Forecast by Country
10.2.3 Asia Pacific Bipolar Disorder Therapeutic Market Size Forecast by Region
10.2.4 South America Bipolar Disorder Therapeutic Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Bipolar Disorder Therapeutic by Country
11 Forecast Market by Type and by Application (2024-2029)
11.1 Global Bipolar Disorder Therapeutic Market Forecast by Type (2024-2029)
11.1.1 Global Forecasted Sales of Bipolar Disorder Therapeutic by Type (2024-2029)
11.1.2 Global Bipolar Disorder Therapeutic Market Size Forecast by Type (2024-2029)
11.1.3 Global Forecasted Price of Bipolar Disorder Therapeutic by Type (2024-2029)
11.2 Global Bipolar Disorder Therapeutic Market Forecast by Application (2024-2029)
11.2.1 Global Bipolar Disorder Therapeutic Sales (K MT) Forecast by Application
11.2.2 Global Bipolar Disorder Therapeutic Market Size (M USD) Forecast by Application (2024-2029)
12 Conclusion and Key Findings

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings